Surfactant Replacement Therapy for Respiratory Distress Syndrome in the Newborn: A Review

Respiratory failure secondary to surfactant deficiency is a major cause of morbidity
and mortality in low birth weight premature infants. Surfactant therapy substantially
reduces mortality and respiratory morbidity for this population.